ClinicalTrials.Veeva

Menu

Validation of Human Papillomavirus Assays and Collection Devices for Self-samples and Urine Samples (VALHUDES)

M

Marc Arbyn

Status

Active, not recruiting

Conditions

Cervical Intraepithelial Neoplasia Grade 2/3

Treatments

Device: Qvintip
Device: Colli-Pee
Device: Evalyn Brush
Diagnostic Test: Abbott RealTime High Risk HPV
Device: Multi-Collect Swab

Study type

Observational

Funder types

Other

Identifiers

NCT03064087
WIV-ISP_2017_001

Details and patient eligibility

About

The VALHUDES study is a Diagnostic Test Accuracy study that aims to document the clinical accuracy of hrHPV testing on urine samples, collected under standardised and optimised conditions, and on two types of vaginal self-samples and compare results with those from matching samples taken by a clinician.

Full description

The samples are collected from patients referred to colposcopy because of prior cervical abnormalities. The patient takes at home two urine samples with the Colli-Pee device (a device that allows to collect first-void urine), the day before the visit to the colposcopy centre. At the colposcopy centre, two vaginal self-samples are taken by the patient herself: one with a cotton swab and a second with a plastic brush. Finally, the gynecologist takes a cervical Pap smear with a Cervex-Brush Combi.

A real-time PCR test will be used to detect DNA of high-risk HPV types. It is possible that in the future also other tests will be validated on these samples. The colposcopy and histological findings will be used as the gold standard. The main purpose of the study is to assess the relative diagnostic tests accuracy of hrHPV testing on self- and urine samples compared to hrHPV testing on cervical samples taken by a clinician. Furthermore, the participating women will receive also a questionnaire which can give insights into the attitudes and preferences of the women with regard to the self-sampling devices.

Enrollment

500 patients

Sex

Female

Ages

25 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with previous abnormal cervical cancer screening test results
  • Women between the ages of 25 and 64

Exclusion criteria

  • Hysterectomised women
  • Women with known pregnancy
  • Non-consenting women
  • Women that are not able to understand and to sign the informed consent

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems